Opus One Solutions, Prime Minister Justin Trudeau recognized as Energy Leaders in Houston

Opus One Solutions, Prime Minister Justin Trudeau recognized as Energy Leaders in Houston

HOUSTON, TEXAS — (Marketwired) — 03/10/17 — Last night, at the 36th annual international meeting of energy industry leaders in Houston, Texas, Opus One Solutions was recognized as an Energy Innovation Pioneer alongside Canadian Prime Minister, Justin Trudeau, who accepted the Global Energy and Environment Leadership Award in recognition of his commitment to sustainability in energy and the environment.Of eight companies from around the world, Opus One was the only Canadian company to be nam

Ideal Power to Present at the 29th Annual ROTH Conference on March 15, 2017

Ideal Power to Present at the 29th Annual ROTH Conference on March 15, 2017

AUSTIN, TX — (Marketwired) — 03/10/17 — (NASDAQ: IPWR), a developer of innovative power conversion technologies, has been invited to present at the being held on March 12-15, 2017 at in Dana Point, California.Ideal Power CFO Tim Burns is scheduled to present on Wednesday, March 15 at 11:30 a.m. Pacific time, and will hold one-on-one meetings with institutional investors.For additional information or to schedule a one-on-one meeting with Ideal Power management, please contact your ROTH rep

Dr. Timothy Saxe, QuickLogic–s CTO, to Deliver Keynote at IoT Summit

Dr. Timothy Saxe, QuickLogic–s CTO, to Deliver Keynote at IoT Summit

SUNNYVALE, CA — (Marketwired) — 03/10/17 — QuickLogic Corporation (NASDAQ: QUIK), a developer of ultra-low power programmable sensor processing, display bridge and programmable logic solutions, announces that its Chief Technology Officer, Dr. Timothy Saxe, will be delivering a keynote address at the IoT Summit in Santa Clara. Dr. Saxe will speak on "Solving the SoC Design Dilemma for IoT Applications with Embedded FPGA (eFPGA.)"Date/Time: March 16, 2017 at 10:45 a.m.
Venue: Santa C

Zenosense, Inc.: MIDS Quantitative Testing Results

VALENCIA, SPAIN — (Marketwired) — 03/10/17 — Zenosense, Inc. (OTCQB: ZENO) ("Zenosense," the "Company"), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac, a Point of Care ("POC") handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition of patients reporting chest pain and with suspected acute myocardial infarct